Surgery Partners, Inc.
US ˙ NasdaqGS ˙ US86881A1007

SecuritySGRY / Surgery Partners, Inc.
InsiderJason Eric Evans
This page shows the track record and history of Evans Jason Eric insider trades in Surgery Partners, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Jason Eric Evans in SGRY / Surgery Partners, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2019-08-20 25,000 5.9500 25,000 5.9500 148,750 358 20.3000 358,750 241.18

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

SGRY / Surgery Partners, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Jason Eric Evans in SGRY / Surgery Partners, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2026-03-16 20,400 12.4700 20,400 12.4700 254,388 11 11.4900 -19,992 -7.86
2026-03-06 11,462 13.7900 11,462 13.7900 158,061
2025-02-07 26,520 25.6500 26,520 25.6500 680,238
2024-03-13 4,840 29.7100 4,840 29.7100 143,796
2024-03-11 1,984 29.4400 1,984 29.4400 58,409
2024-03-04 9,070 30.6100 9,070 30.6100 277,633
2024-02-12 5,780 35.0800 5,780 35.0800 202,762
2023-12-19 5,000 33.4400 5,000 33.4400 167,200
2023-03-31 7,674 34.2600 7,674 34.2600 262,911
2023-03-15 99 30.1000 99 30.1000 2,980
2023-03-14 12,399 31.1000 12,399 31.1000 385,609
2023-03-13 10,300 30.1100 10,300 30.1100 310,133
2023-02-27 20,042 33.5300 20,042 33.5300 672,008
2023-02-13 5,884 33.9000 5,884 33.9000 199,468
2022-04-01 11,467 54.9600 11,467 54.9600 630,226
2022-03-15 14,065 49.3000 14,065 49.3000 693,404
2022-03-11 5,061 54.6600 5,061 54.6600 276,634
2022-02-28 14,071 52.2500 14,071 52.2500 735,210

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

SGRY / Surgery Partners, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2026-03-16 2026-03-16 4 Evans Jason Eric SGRY Common Stock S - Sale D 12.4700 -20,400 -254 920,386
2026-03-09 2026-03-06 4 Evans Jason Eric SGRY Common Stock S - Sale D 13.7900 -11,462 -158 662,680
2026-03-09 2026-03-05 4 Evans Jason Eric SGRY Common Stock A - Award D 14.1100 136,363 1,924 940,786
2026-03-09 2026-03-05 4 Evans Jason Eric SGRY Common Stock A - Award D 14.1100 141,743 2,000 804,423
2025-03-06 2025-03-04 4 Evans Jason Eric SGRY Common Stock A - Award D 23.8000 29,411 700 674,142
2025-03-06 2025-03-04 4 Evans Jason Eric SGRY Common Stock A - Award D 23.8000 84,033 2,000 644,731
2025-02-10 2025-02-07 4 Evans Jason Eric SGRY Common Stock S - Sale D 25.6500 -26,520 -680 560,698
2025-02-04 2025-01-31 4 Evans Jason Eric SGRY Common Stock A - Award D 111,048 587,218
2024-12-16 2024-12-12 4 Evans Jason Eric SGRY Common Stock M - Exercise D 11.5400 16,500 190 476,170
2024-03-13 2024-03-13 4 Evans Jason Eric SGRY Common Stock S - Sale D 29.7100 -4,840 -144 459,670
2024-03-13 2024-03-11 4 Evans Jason Eric SGRY Common Stock S - Sale D 29.4400 -1,984 -58 464,510
2024-03-06 2024-03-04 4 Evans Jason Eric SGRY Common Stock S - Sale D 30.6100 -9,070 -278 466,494
2024-03-01 2024-02-28 4 Evans Jason Eric SGRY Common Stock A - Award D 31.1800 56,446 1,760 475,564
2024-02-14 2024-02-12 4 Evans Jason Eric SGRY Common Stock S - Sale D 35.0800 -5,780 -203 419,118
2023-12-21 2023-12-19 4 Evans Jason Eric SGRY Common Stock S - Sale D 33.4400 -5,000 -167 419,898
2023-07-03 2023-06-29 4 Evans Jason Eric SGRY Common Stock S - Sale D 45.1000 -1,892 -85 424,898
2023-04-03 2023-03-31 4 Evans Jason Eric SGRY Common Stock S - Sale D 34.2600 -7,674 -263 426,790
2023-03-28 2023-03-24 4 Evans Jason Eric SGRY Common Stock A - Award D 20,408 434,464
2023-03-15 2023-03-15 4 Evans Jason Eric SGRY Common Stock S - Sale D 30.1000 -99 -3 414,056
2023-03-15 2023-03-14 4 Evans Jason Eric SGRY Common Stock S - Sale D 31.1000 -12,399 -386 414,155
2023-03-15 2023-03-13 4 Evans Jason Eric SGRY Common Stock S - Sale D 30.1100 -10,300 -310 426,554
2023-03-06 2023-03-02 4 Evans Jason Eric SGRY Common Stock A - Award D 32.8600 66,950 2,200 436,854
2023-03-01 2023-02-27 4 Evans Jason Eric SGRY Common Stock S - Sale D 33.5300 -20,042 -672 369,904
2023-02-15 2023-02-13 4 Evans Jason Eric SGRY Common Stock S - Sale D 33.9000 -5,884 -199 389,946
2022-04-04 2022-04-01 4 Evans Jason Eric SGRY Common Stock S - Sale D 54.9600 -11,467 -630 397,872
2022-03-17 2022-03-15 4 Evans Jason Eric SGRY Common Stock S - Sale D 49.3000 -14,065 -693 409,339
2022-03-15 2022-03-11 4 Evans Jason Eric SGRY Common Stock A - Award D 54.0300 37,016 2,000 423,404
2022-03-14 2022-03-11 4 Evans Jason Eric SGRY Common Stock S - Sale D 54.6600 -5,061 -277 386,388
2022-03-02 2022-02-28 4 Evans Jason Eric SGRY Common Stock S - Sale D 52.2500 -14,071 -735 361,717
2022-03-02 2022-02-10 4 Evans Jason Eric SGRY Common Stock A - Award D 42.0400 29,732 1,250 391,449
2021-04-01 2021-04-01 4 Evans Jason Eric SGRY Common Stock F - Taxes D 44.2600 -11,366 -503 375,788
2021-03-29 2021-03-26 4 Evans Jason Eric SGRY Common Stock F - Taxes D 43.7500 -3,372 -148 387,154
2021-03-25 2021-03-25 4 Evans Jason Eric SGRY Common Stock A - Award D 8,867 390,822
2021-03-17 2021-03-13 4 Evans Jason Eric SGRY Common Stock F - Taxes D 42.0600 -12,829 -540 381,955
2021-03-12 2021-03-10 4 Evans Jason Eric SGRY Common Stock A - Award D 14,866 394,784
2021-03-12 2021-03-10 4 Evans Jason Eric SGRY Common Stock A - Award D 14,866 394,784
2021-02-26 2021-02-24 4 Evans Jason Eric SGRY Common Stock A - Award D 97,809 365,052
2020-03-31 2020-03-27 4 Evans Jason Eric SGRY Common Stock A - Award D 6.6200 57,779 382 267,243
2020-03-17 2020-03-13 4 Evans Jason Eric SGRY Common Stock A - Award D 97,809 209,464
2019-08-21 2019-08-20 4 Evans Jason Eric SGRY Common Stock P - Purchase D 5.9500 25,000 149 111,655
2019-04-03 2019-04-01 4 Evans Jason Eric SGRY Stock Option (Right to Buy) A - Award D 11.54 500,000 500,000
2019-04-03 2019-04-01 4 Evans Jason Eric SGRY Common Stock A - Award D 86,655 86,655
P
Acquisto sul mercato aperto o privato di un titolo non derivato o derivato
S
Vendita sul mercato aperto o privato di un titolo non derivato o derivato
A
Concessione, assegnazione o altra acquisizione di titoli dall'azienda (ad esempio un'opzione)
C
Conversione di un derivato
D
Vendita o trasferimento di titoli alla società
F
Pagamento del prezzo di esercizio o del debito fiscale con la quota di titoli ricevuta dalla società
G
Regalo di titoli da parte o a favore dell'insider
K
Equity swap e operazioni di copertura analoghe
M
Esercizio o conversione di un titolo derivato ricevuto dall'azienda (ad esempio un'opzione)
V
Una transazione dichiarata volontariamente sul modulo 4
J
Altro (accompagnato da una nota a piè di pagina che descriva l'operazione)